Skip to main content
. 2022 Jun 1;13:877807. doi: 10.3389/fendo.2022.877807

Figure 4.

Figure 4

Determination of metabolites in tryptophan-kynurenine pathway associated with the obesity risk in women with PCOS. (A, B) The plasma level changes of kynurenic acid (A) and quinolinic acid (B) in overweight/obese PCOS patients compared with normal weight PCOS women. **p < 0.01; *p < 0.05. (C) The odds ratios (95% CIs) of obesity in women with PCOS per 1 SD increase in plasma abundance of KYNA, kynurenic acid and QA, quinolinic acid before and after adjusting for baseline age, LH, androstenedione and AMH.